US Broker Ratings

Amedisys Inc (AMED) Investor Outlook: Strong Healthcare Growth with a Balanced Analyst Consensus

Amedisys Inc (AMED), a key player in the healthcare sector, is drawing investor attention with its strategic focus on home-based medical care services. Headquartered in Baton..

Merus N.V. (MRUS) Stock Analysis: A Strong Buy with a 71.55% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to immuno-oncology. Based in the Netherlands, this..

Haemonetics Corporation (HAE) Stock Analysis: Unveiling a 20.76% Potential Upside in Healthcare Innovation

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector, is drawing attention from investors with a noteworthy potential upside of 20.76%. As a leading..

Concentra Group Holdings (CON) Stock Analysis: Healthcare Leader with a Promising 37% Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers a compelling investment opportunity...

ICU Medical, Inc. (ICUI) Stock Analysis: Navigating a 43.55% Potential Upside in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is catching the eyes of investors with a..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 59.71% Potential Upside Sparks Investor Interest

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering gene-editing company, continues to captivate investors with its cutting-edge CRISPR/Cas9 technology, which promises transformative advances in genetic medicine. Although..

Zai Lab Limited (ZLAB) Stock Analysis: A 53% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB) stands out in the biotechnology industry, not just for its innovative approach to addressing critical health conditions like oncology, immunology, neuroscience,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 43% Upside Potential in Gene Therapy Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning leader in the biotechnology sector, has captured investor attention with its impressive market cap of $4.13 billion and a..

Integer Holdings Corporation (ITGR) Stock Analysis: Unlocking a 22.93% Potential Upside in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), with its robust presence in the healthcare sector, stands out as a significant player in the medical device industry. Headquartered in..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings Signal Potential Upside for Investors

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector’s medical devices industry, has been making waves with its innovative ophthalmic pharmaceutical and medical technology..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring Growth Potential in the Eye Health Sector

Bausch + Lomb Corporation (NYSE: BLCO), a global leader in eye health, presents an intriguing case for investors, particularly in the healthcare sector. With a market..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 66% Upside Potential

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector with a focus on medical devices, is capturing investor attention with its innovative..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling Growth Potential Amidst a Surge in Revenue

TransMedics Group, Inc. (NASDAQ: TMDX) stands at the forefront of revolutionizing organ transplant therapy with its cutting-edge medical technology solutions. As a prominent player in the..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Powerhouse with 34.62% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents itself as a compelling investment opportunity in the biotechnology sector, particularly for those interested in RNA-targeted therapies. With a market..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Promising 59.55% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is catching the attention of savvy investors with its compelling growth prospects and a significant potential upside of 59.55%. As a..

ICON plc (ICLR) Stock Analysis: Healthcare Giant with a 16.72% Upside Potential

ICON plc (NASDAQ: ICLR) stands as a prominent player in the global healthcare sector, specializing in diagnostics and research. Headquartered in Dublin, Ireland, the company has..

ADMA Biologics Inc (ADMA) Investor Outlook: Exploring a 61% Upside Potential in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, presents a compelling case for investors with its promising growth trajectory and substantial upside..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 28% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector with its focus on developing therapeutics for rare diseases, notably through its lead product..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 130% Potential Upside Amidst Biotech Innovation

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing investor attention with its innovative approach to RNA therapeutics, promising substantial growth in the biotechnology sector. Despite its current..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook with a Promising 26.83% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of the investor community with its intriguing investment proposition, particularly in the realm of rare neuroendocrine diseases...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds